These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
    Author: Balwierz W, Moryl-Bujakowska A, Balwierz A, Pawińska K.
    Journal: Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890.
    Abstract:
    Neutropenia is the most often side effect during antineoplastic treatment. In this article current recommendations for clinical applications of granulocyte and granulocyto-macrophage hematopoietic factors and possibility of protection of neutropenia, and its serious complications in pediatric oncology are presented.
    [Abstract] [Full Text] [Related] [New Search]